FORTREA HOLDINGS INC. Amortization of Intangible Assets
FORTREA HOLDINGS INC. (FTRE) reported Amortization of Intangible Assets of $58.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-26
- FORTREA HOLDINGS INC. amortization of intangible assets for the quarter ending 2024-06-30 was $15.10M, a 1.95% decline year-over-year.
- FORTREA HOLDINGS INC. amortization of intangible assets for the quarter ending 2024-03-31 was $15.30M, a 2.00% increase year-over-year.
- FORTREA HOLDINGS INC. amortization of intangible assets for the quarter ending 2023-12-31 was $12.80M, a 0.00% change year-over-year.
- FORTREA HOLDINGS INC. amortization of intangible assets for the quarter ending 2023-09-30 was $16.00M, a 1.23% decline year-over-year.
- FORTREA HOLDINGS INC. amortization of intangible assets for fiscal 2025 was $58.30M, a 4.11% decline from fiscal 2024.
- FORTREA HOLDINGS INC. amortization of intangible assets for fiscal 2024 was $60.80M, a 0.16% increase from fiscal 2023.
- FORTREA HOLDINGS INC. amortization of intangible assets for fiscal 2023 was $60.70M, a 2.88% decline from fiscal 2022.
- FORTREA HOLDINGS INC. amortization of intangible assets for fiscal 2022 was $62.50M, a 55.36% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $58.30M 10-K · filed 2026-02-26 | ||||||
| 2024-12-31 | $60.80M 10-K · filed 2026-02-26 | ||||||
| 2024-06-30 | $15.10M 10-Q · filed 2024-08-12 | $30.40M 10-Q · filed 2024-08-12 | $43.20M derived: sum of 3 quarters · filed 2026-02-26 | $59.20M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $15.30M 10-Q · filed 2024-05-24 | $28.10M derived: sum of 2 quarters · filed 2026-02-26 | $44.10M derived: sum of 3 quarters · filed 2026-02-26 | $59.50M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $28.80M derived: sum of 2 quarters · filed 2026-02-26 | $44.20M derived: sum of 3 quarters · filed 2026-02-26 | $60.70M 10-K · filed 2026-02-26 | $63.80M 10-K · filed 2024-03-13 | ||
| 2023-09-30 | $16.00M 10-Q · filed 2023-11-13 | $31.40M derived: sum of 2 quarters · filed 2024-08-12 | $47.90M 10-Q · filed 2023-11-13 | $59.20M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | $15.40M 10-Q · filed 2024-08-12 | $16.00M 10-Q · filed 2023-08-14 | $30.40M 10-Q · filed 2024-08-12 | $16.60M 10-Q · filed 2023-08-14 | $43.20M derived: sum of 3 quarters · filed 2025-03-03 | $59.40M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $15.00M 10-Q · filed 2024-05-24 | $27.80M derived: sum of 2 quarters · filed 2025-03-03 | $44.00M derived: sum of 3 quarters · filed 2025-03-03 | $75.90M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2022-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $29.00M derived: sum of 2 quarters · filed 2025-03-03 | $60.90M derived: sum of 3 quarters · filed 2025-03-03 | $62.50M 10-K · filed 2025-03-03 | $65.70M 10-K · filed 2024-03-13 | ||
| 2022-09-30 | $16.20M 10-Q · filed 2023-11-13 | $48.10M derived: sum of 2 quarters · filed 2023-11-13 | $49.70M 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | $31.90M 10-Q · filed 2023-08-14 | $33.50M 10-Q · filed 2023-08-14 | |||||
| 2021-12-31 | $140.00M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |